Cargando…

Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading

Neuroendocrine neoplasms (NENs) are rare, heterogeneous and ubiquitous tumors commonly localized in the gastrointestinal tract, lung, and pancreas. The clinical behavior of NEN is highly unpredictable; in fact, low-grade cases can unexpectedly be associated with metastases. Currently, the 2010 WHO N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cavalcanti, Elisabetta, Armentano, Raffaele, Valentini, Anna Maria, Chieppa, Marcello, Caruso, Maria Lucia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596583/ https://www.ncbi.nlm.nih.gov/pubmed/28837143 http://dx.doi.org/10.1038/cddis.2017.401

Ejemplares similares

Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors Grades
por: Cavalcanti, Elisabetta, et al.
Publicado: (2020)

PD-L1 Expression and Immune Cell Infiltration in Gastroenteropancreatic (GEP) and Non-GEP Neuroendocrine Neoplasms With High Proliferative Activity
por: Ferrata, Martina, et al.
Publicado: (2019)

Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
por: Kaliszewski, Krzysztof, et al.
Publicado: (2022)

The Role of the Microbiome in Gastroentero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs)
por: Mohamed, Amr, et al.
Publicado: (2022)

PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
por: Ali, Abir Salwa, et al.
Publicado: (2020)

SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) 2014
por: Garcia-Carbonero, R., et al.
Publicado: (2014)

Biochemical diagnosis of neuroendocrine GEP tumor.
por: Oberg, K.
Publicado: (1997)

The Glasgow Prognostic Score Predicts Survival Outcomes in Neuroendocrine Neoplasms of the Gastro–Entero–Pancreatic (GEP-NEN) System
por: Gebauer, Niklas, et al.
Publicado: (2022)

The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs
por: Kim, Seung Tae, et al.
Publicado: (2016)

Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms
por: La Rosa, Stefano
Publicado: (2021)

Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study
por: Masui, Toshihiko, et al.
Publicado: (2020)

Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3
por: Ali, Abir Salwa, et al.
Publicado: (2020)

GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (GEP-NETs) - APPROACH TO DIAGNOSIS AND MANAGEMENT
por: Oladejo, A.O.
Publicado: (2009)

mTOR Pathway in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NETs)
por: Zanini, Sara, et al.
Publicado: (2020)

Deletion of TNF in Winnie-APC(Min/+) Mice Reveals Its Dual Role in the Onset and Progression of Colitis-Associated Colorectal Cancer
por: Verna, Giulio, et al.
Publicado: (2022)

Association of Alpha B-Crystallin Expression with Tumor Differentiation Grade in Colorectal Cancer Patients
por: Pagano, Cristina, et al.
Publicado: (2021)

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness
por: Barrea, Luigi, et al.
Publicado: (2018)

Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine Neoplasms
por: Lacombe, Caroline, et al.
Publicado: (2021)

Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET)
por: Lamberti, Giuseppe, et al.
Publicado: (2023)

Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
por: Uri, Inbal, et al.
Publicado: (2018)

The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms
por: Venizelos, Andreas, et al.
Publicado: (2021)

Tumor microenvironment immune types in gastric cancer are associated with mismatch repair however, not HER2 status
por: Valentini, Anna Maria, et al.
Publicado: (2019)

Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms
por: Leoncini, Emanuele, et al.
Publicado: (2017)

PDGFRα expression as a novel therapeutic marker in well-differentiated neuroendocrine tumors
por: Cavalcanti, Elisabetta, et al.
Publicado: (2018)

PD-L1 expression and patient outcomes in gastrointestinal neuroendocrine neoplasm: a meta-analysis
por: Lee, Woojoo, et al.
Publicado: (2021)

Genomic Profiling of Metastatic Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients in the Personalized-Medicine Era
por: Kim, Seung Tae, et al.
Publicado: (2016)

Efficacy of ipilimumab and nivolumab in patients with high-grade neuroendocrine neoplasms
por: Al-Toubah, T., et al.
Publicado: (2021)

Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms
por: Koenig, Alexander, et al.
Publicado: (2017)

Dysbiosis Triggers ACF Development in Genetically Predisposed Subjects
por: De Santis, Stefania, et al.
Publicado: (2021)

PD-L1 expression in colorectal cancer defines three subsets of tumor immune microenvironments
por: Valentini, Anna Maria, et al.
Publicado: (2018)

An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide
por: Bevere, Michele, et al.
Publicado: (2023)

The Role of Alternative Lymph Node Classification Systems in Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NEN): Superiority of a LODDS Scheme Over N Category in Pancreatic NEN (pNEN)
por: Krieg, Sarah, et al.
Publicado: (2023)

Crohn’s Disease Following Rituximab Treatment for Follicular Lymphoma in a Patient with Synchronous Gastric Signet Ring Cells Carcinoma: A Case Report and Literature Review
por: Cavalcanti, Elisabetta, et al.
Publicado: (2020)

Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms
por: Bocian-Jastrzębska, Agnes, et al.
Publicado: (2023)

Role of surgical treatments in high-grade or advanced gastroenteropancreatic neuroendocrine neoplasms
por: Que, Qing-Yang, et al.
Publicado: (2022)

Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine Neoplasms
por: Takayanagi, Daisuke, et al.
Publicado: (2022)

Comparison of Serum and Urinary 5-Hydroxyindoleacetic Acid as Biomarker for Neuroendocrine Neoplasms
por: Becker, Anna, et al.
Publicado: (2021)

GEPS: the Gene Expression Pattern Scanner
por: Wang, Yu-Peng, et al.
Publicado: (2006)

Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms
por: Detjen, Katharina M., et al.
Publicado: (2021)

Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms
por: Corsello, Andrea, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6cftp2prchac9p2ec02marnao3